JGL registered a company in the USA, in Manhattan – the heart of New York. JGL North America LLC Over the last few years JGL business has gone global and the company now operates in different EU markets with a variety of projects and a range of partners. Having realized the Latanoprost project and obtained the GMP certificate, we began cooperation with partners across the European Union, which accelerated the implementation of our own development projects and independent DCP registration procedures in the EU (simultaneous registration in several markets). This created new opportunities for licensing, particularly in regards to expanding our licensing out activities.
The aim and purpose of JGL’s New York subsidiary is a fast entry into this large and very attractive market, in accordance with JGL’s globalization strategy and business development.